Commons Capital’s Sanara MedTech SMTI Stock Holding History

Commons Capital’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,043	Closed	-$60K	–	212
2021 Q4	$60K	Buy	+2,043	New	+$64.3K	0.06%	170

Other funds holding SMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

NRC

North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Commons Capital's SMTI Position: Q1 2022 in Review

Commons Capital sold out of Sanara MedTech (SMTI) in Q1 2022, closing a stake of 2,043 shares — an estimated $60K sold.

Commons Capital first reported a position in SMTI in Q4 2021 and held it in 1 quarter. The position peaked at $60K in Q4 2021. 21 funds tracked by Wall St. Rank hold SMTI as of Q1 2022.

Commons Capital reported no remaining Sanara MedTech position as of Q1 2022 after selling out during the quarter.
Commons Capital sold 2,043 Sanara MedTech shares in Q1 2022, an estimated $60K.
Commons Capital first reported a position in Sanara MedTech in Q4 2021 and held it in 1 quarter.
Commons Capital's Sanara MedTech position peaked at $60K in Q4 2021.
21 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2022.

Based on Commons Capital's 13F filing for Q1 2022, filed 13 May 2022.